Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 35 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience.
Pepe F, Russo G, Venuta A, Scimone C, Nacchio M, Pisapia P, Goteri G, Barbisan F, Chiappetta C, Pernazza A, Campagna D, Giordano M, Perrone G, Sabarese G, Altimari A, de Biase D, Tallini G, Calistri D, Chiadini E, [...] Troncone G
Oncol Ther, 12(1):73-95, 11 Jan 2024
Cited by: 0 articles | PMID: 38200361 | PMCID: PMC10881930
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack.
Cerbone L, Orecchia S, Bertino P, Delfanti S, de Angelis AM, Grosso F
Cancers (Basel), 15(24):5716, 06 Dec 2023
Cited by: 0 articles | PMID: 38136262 | PMCID: PMC10741845
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
DNA Damage Regulates the Functions of the RNA Binding Protein Sam68 through ATM-Dependent Phosphorylation.
Stagni V, Orecchia S, Mignini L, Beji S, Antonioni A, Caggiano C, Barilà D, Bielli P, Sette C
Cancers (Basel), 14(16):3847, 09 Aug 2022
Cited by: 5 articles | PMID: 36010841 | PMCID: PMC9405969
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088).
Monsellato I, Garibaldi E, Cassinotti E, Baldari L, Boni L, Elmore U, Delpini R, Rosati R, Perinotti R, Alongi F, Bertocchi E, Gori S, Ruffo G, Pernazza G, Pulighe F, De Nisco C, Morpurgo E, Contardo T, Mammano E, [...] Orecchia S
Trials, 21(1):678, 25 Jul 2020
Cited by: 2 articles | PMID: 32711544 | PMCID: PMC7382047
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).
Monsellato I, Alongi F, Bertocchi E, Gori S, Ruffo G, Cassinotti E, Baldari L, Boni L, Pernazza G, Pulighe F, De Nisco C, Perinotti R, Morpurgo E, Contardo T, Mammano E, Elmore U, Delpini R, Rosati R, Perna F, [...] Orecchia S
BMC Cancer, 19(1):1215, 16 Dec 2019
Cited by: 3 articles | PMID: 31842784 | PMCID: PMC6912945
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correction to: Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).
Monsellato I, Alongi F, Bertocchi E, Gori S, Ruffo G, Cassinotti E, Baldari L, Boni L, Pernazza G, Pulighe F, De Nisco C, Perinotti R, Morpurgo E, Contardo T, Mammano E, Elmore U, Delpini R, Rosati R, Perna F, [...] Orecchia S
BMC Cancer, 20(1):128, 17 Feb 2020
Cited by: 0 articles | PMID: 32066408 | PMCID: PMC7026949
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.
Milosevic V, Kopecka J, Salaroglio IC, Libener R, Napoli F, Izzo S, Orecchia S, Ananthanarayanan P, Bironzo P, Grosso F, Tabbò F, Comunanza V, Alexa-Stratulat T, Bussolino F, Righi L, Novello S, Scagliotti GV, Riganti C
Int J Cancer, 146(1):192-207, 04 Jun 2019
Cited by: 21 articles | PMID: 31107974
Add to export list
Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study.
De Laurentiis M, Bonfadini C, Lorusso V, Cilenti G, Di Rella F, Altavilla G, Otero M, Ardizzoia A, Marchetti P, Peverelli G, Amoroso D, Vecchio S, Fiorio E, Orecchia S
Support Care Cancer, 26(12):4021-4029, 25 Jun 2018
Cited by: 5 articles | PMID: 29943152
Add to export list
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.
Kopecka J, Salaroglio IC, Righi L, Libener R, Orecchia S, Grosso F, Milosevic V, Ananthanarayanan P, Ricci L, Capelletto E, Pradotto M, Napoli F, Di Maio M, Novello S, Rubinstein M, Scagliotti GV, Riganti C
Lung Cancer, 120:34-45, 26 Mar 2018
Cited by: 18 articles | PMID: 29748013
Add to export list
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.
Riganti C, Lingua MF, Salaroglio IC, Falcomatà C, Righi L, Morena D, Picca F, Oddo D, Kopecka J, Pradotto M, Libener R, Orecchia S, Bironzo P, Comunanza V, Bussolino F, Novello S, Scagliotti GV, Di Nicolantonio F, Taulli R
Oncoimmunology, 7(3):e1398874, 27 Nov 2017
Cited by: 26 articles | PMID: 29399399 | PMCID: PMC5790353
Add to export list Free full text in Europe PMC
Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.
Vázquez R, Licandro SA, Astorgues-Xerri L, Lettera E, Panini N, Romano M, Erba E, Ubezio P, Bello E, Libener R, Orecchia S, Grosso F, Riveiro ME, Cvitkovic E, Bekradda M, D'Incalci M, Frapolli R
Int J Cancer, 140(1):197-207, 19 Sep 2016
Cited by: 21 articles | PMID: 27594045
Add to export list
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I, Comar M, Puozzo A, Stendardo M, Boschetto P, Orecchia S, Libener R, Guaschino R, Pietrobon S, Ferracin M, Negrini M, Martini F, Bovenzi M, Tognon M
Oncotarget, 7(50):82700-82711, 01 Dec 2016
Cited by: 34 articles | PMID: 27716620 | PMCID: PMC5347725
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma.
Salaroglio IC, Campia I, Kopecka J, Gazzano E, Orecchia S, Ghigo D, Riganti C
Oncotarget, 6(2):1128-1142, 01 Jan 2015
Cited by: 22 articles | PMID: 25544757 | PMCID: PMC4359222
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.
Ortolan E, Giacomino A, Martinetto F, Morone S, Lo Buono N, Ferrero E, Scagliotti G, Novello S, Orecchia S, Ruffini E, Rapa I, Righi L, Volante M, Funaro A
Oncotarget, 5(15):6191-6205, 01 Aug 2014
Cited by: 12 articles | PMID: 25026285 | PMCID: PMC4171622
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
What do general practitioners think about acupuncture?
Fanì M, Maestro M, Mandas A, Orecchia S, Le Gouëllec L, Pedrali T
Ann Ig, 26(3):213-218, 01 May 2014
Cited by: 3 articles | PMID: 24998212
Add to export list
Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma.
Betta PG, Magnani C, Bensi T, Trincheri NF, Orecchia S
Arch Pathol Lab Med, 136(3):253-261, 01 Mar 2012
Cited by: 24 articles | PMID: 22372901
Add to export list Review
Antioxidants prevent the RhoA inhibition evoked by crocidolite asbestos in human mesothelial and mesothelioma cells.
Aldieri E, Riganti C, Silvagno F, Orecchia S, Betta PG, Doublier S, Gazzano E, Polimeni M, Bosia A, Ghigo D
Am J Respir Cell Mol Biol, 45(3):625-631, 21 Jan 2011
Cited by: 7 articles | PMID: 21257924
Add to export list
In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects.
Zanellato I, Boidi CD, Lingua G, Betta PG, Orecchia S, Monti E, Osella D
Cancer Chemother Pharmacol, 67(2):265-273, 06 Apr 2010
Cited by: 13 articles | PMID: 20369238
Add to export list
Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma.
Lazzarini R, Moretti S, Orecchia S, Betta PG, Procopio A, Catalano A
Clin Cancer Res, 14(16):5099-5107, 01 Aug 2008
Cited by: 22 articles | PMID: 18698027
Add to export list
Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha.
Riganti C, Doublier S, Aldieri E, Orecchia S, Betta PG, Gazzano E, Ghigo D, Bosia A
Eur Respir J, 32(2):443-451, 02 Apr 2008
Cited by: 12 articles | PMID: 18385176
Add to export list
Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.
Riganti C, Orecchia S, Pescarmona G, Betta PG, Ghigo D, Bosia A
Int J Cancer, 119(1):17-27, 01 Jul 2006
Cited by: 37 articles | PMID: 16450390
Add to export list
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly.
Cartenì G, Giannetta L, Ucci G, De Signoribus G, Vecchione A, Pinotti G, Puglisi F, Contillo A, Pezzella G, Orecchia S, Beccaglia P, OBI/EPO-ITA-01/1 study group
Support Care Cancer, 15(9):1057-1066, 13 Apr 2007
Cited by: 11 articles | PMID: 17431689
Add to export list
Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition.
Riganti C, Orecchia S, Silvagno F, Pescarmona G, Betta PG, Gazzano E, Aldieri E, Ghigo D, Bosia A
Am J Respir Cell Mol Biol, 36(6):746-756, 22 Feb 2007
Cited by: 3 articles | PMID: 17322126
Add to export list
Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.
Martarelli D, Catalano A, Procopio A, Orecchia S, Libener R, Santoni G
BMC Cancer, 6:130, 17 May 2006
Cited by: 18 articles | PMID: 16704740 | PMCID: PMC1483896
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance.
Orecchia S, Schillaci F, Salvio M, Libener R, Betta PG
Lung Cancer, 45 Suppl 1:S37-43, 01 Aug 2004
Cited by: 22 articles | PMID: 15261432
Add to export list

1-25 of 35 results

1 2

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding